From the December 2009 issue

We have notified FDA about a potentially hazardous condition due to name similarity. DUREZOL (difluprednate ophthalmic emulsion) 0.05% (www.durezol.com) is a topical ophthalmic corticosteroid used to treat postoperative inflammation associated with ocular surgery. DURASAL is a topical solution containing 26% salicylic acid in a film-forming vehicle (www.eloracpharma.com/products/Durasal.asp) used to treat common and plantar warts. Accidental administration of Durasal in the eye would obviously be disastrous. Fortunately, the brush applicator packaging for Durasal makes such a mix-up unlikely. The product is also clearly labeled that it is not for ophthalmic use. However, we know that even stranger things have happened. To be safe, these products should be segregated in pharmacy and hospital storage areas.